Economics of Innovation
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.
European Union Pharmaceutical Markets: A Case for Differential Pricing?
11 August 2015
This article looks at how theory could be put into practice suggesting ways to implement a differential pricing system for branded medicines in the EU that…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
This post summarises OHE’s activities at this year HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad and a new drug…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
This post summarises OHE’s activities at the upcoming HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad, a framework for developing…
New Business Models for Antibiotics. What Can We Learn from Other Industries?
7 April 2015
The business model for antibiotics is broken. We looked at other industries facing conceptually similar challenges – particularly when the incentive for R&D is delinked from…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
A new OHE Consulting Report considers the data capabilities in the UK for monitoring medicine use according to indication using real world data.
Medical Research: How Long Does it Take?
10 February 2015
It is surprisingly hard to measure how long medical research takes. A recently published study by OHE, Brunel and RAND Europe shows a better way to…
Benefiting Sooner from Medical Research
3 February 2015
Recently published study by OHE, Brunel University, RAND Europe and Kings College London analyses time lags in medical research and where to shorten them.
OHE Welcomes Dr. Aslam Anis
28 January 2015
Dr. Aslam Anis, Director of the Centre for Health Evaluation and Outcomes Sciences (CHEOS) in Canada will undertake a short sabbatical with the Office of Health…
Dementia: The R&D Landscape
1 November 2015
This OHE Research Paper provides an overview of the current dementia R&D landscape. The research was undertaken by OHE for Imperial College and the UK Department of Health.